{
  "documents": [
    "Review Personalized Nutrition in Chronic Kidney Disease NishigandhaPradhan1, 2, , JenniferKerner2, LucianaA. Campos3 andMirelaDobre1, 2 1 SchoolofMedicine, CaseWesternUniversity, Cleveland, OH44106, USA 2 DepartmentofMedicine, DivisionofNephrologyandHypertension, UniversityHospitalsClevelandMedical Center, Cleveland, OH44106, USA 3 CenterofInnovation, TechnologyandEducation(CITE)atAnhembiMorumbiUniversityAnimaInstitute, SãoJosédosCampos12247-016, Brazil Correspondence: nishigandha. pradhanuhhospitals. org; Tel. : 216-844-8341; Fax: 216-844-3167 Abstract: Apersonalizedapproachtonutritioninpatientswithchronickidneydisease (chronic kidney disease) represents a promising paradigm shift in disease management, moving beyond traditionalone-size-fits-alldietaryrecommendations. PatientswithCKDoftenhaveother comorbiditiesandfaceuniquenutritionalchallenges, includingprotein-energywasting (protein-energy wasting), sarcopenia, andimpairedrenalexcretionofnutrients, whichcomplicatedietary planning. Currentguidelinesfocusprimarilyonnutrientrestrictionssuchaslimitingprotein, Sodium, Potassium, andphosphorus. However, thesegeneralizedrecommendations oftenresultinsuboptimaladherenceandoutcomes. Personalizednutrition, whichadapts dietaryrecommendationstoindividualcharacteristics, suchasgenotype, phenotype, and socio-culturalpreferences, hasgainedtractionacrossvariouschronicdiseases. However, itsapplicationinnephrologyremainsunderexplored, anddespitepromisingresultsfrom studiessuchasFood4Me, questionsremainaboutthereal-worldimpactofsuchstrategies. Theaimsofthisrevieware(1)tosummarizetheevidenceonthecurrentstateofnutritional recommendationsinCKD, (2)todiscusstheemergingroleofmulti-omicsapproachesininformingpersonalizednutritionadviceinCKD, and(3)toprovideanopiniononnutritional challengesfacedbypatientswithCKDandtheimportanceofcollaborationwiththerenal dietician. Weconcludethatdespitebarriers, suchasthecostanddataintegration, personalizednutritionholdsthepotentialtoimproveCKDoutcomes, enhancequalityoflife, and empowerpatientsthroughtailoreddietarystrategiesforbetterdiseasemanagement. Keywords: personalizednutrition; chronickidneydisease; renaldiet AcademicEditor: SilvioMaringhini Received: 10January2025 Revised: 21February2025 Accepted: 28February2025 1. Background Published: 6March2025 Theglobalincidenceandprevalenceofchronickidneydisease(chronic kidney disease)areincreasing Citation: Pradhan, N. ; Kerner, J. ; Campos, L. A. ; Dobre, M. Personalized inparalleltorisingprevalencesofobesity, diabetesmellitus, hypertension, andmetabolic NutritioninChronicKidneyDisease. syndrome 1. All these conditions have many overlapping risk factors pertaining to Biomedicines2025, 13, 647. dietandlifestyle, suchasexcessivecaloricintake, consumptionofultraprocessedfood, inadequate physical activity, and smoking. It is estimated that about 11 million deaths 10. 3390/biomedicines13030647 globally2andabouthalfofalldeathsduetocardiometabolicdiseasesintheUS3canbe Copyright: 2025bytheauthors. attributedtopoordiet. Withanincreaseintheawarenessofthecentralroleplayedbydietin LicenseeMDPI, Basel, Switzerland. thedevelopmentofthesechronicdiseases, thereisgreaterfocusonfoodismedicine4, 5. Thisarticleisanopenaccessarticle Theconceptofpersonalizednutrition, whichtailorsdietaryrecommendationstoindividual distributedunderthetermsand characteristics, includinggenotype, phenotype, andsocio-culturalfactors, recognizesthat conditionsoftheCreativeCommons Attribution(CCBY)license individualresponsestonutritioncanvarysignificantly. Despiteprogressinunderstanding ( the complex interplay between diet and these individual factors in the course of some licenses/by/4. 0/). Biomedicines2025, 13, 647 Biomedicines2025, 13, 647 2of17 diseases, such as obesity 6, 7, cardiovascular disease 8, metabolic syndrome 8, and Diabetes9, 10, datainthefieldofkidneydiseasesremainlimited. Thisreviewassesses the current state of nutritional guidelines for the management of chronic kidney disease, the emerging role of multi-omics in informing personalized nutrition advice in chronic kidney disease and highlights the associated nutritional challenges. It further explores the barriers to implementing personalizednutritionstrategiesinclinicalpracticeforpatientswithCKDandoutlinesa potentialframeworkforadvancingindividualizednutritionalapproachestooptimizeCKD managementonapatient-specificbasisviatwovignettes. 2. EmergenceofPersonalizedNutrition Traditionally, nutritional advice has been targeted toward populations with some stratification based on broad characteristics like age, sex, and pregnancy status. The recognitionthatonesizedoesnotfitallandthatindividualresponsestonutritionvary significantlyduetointrinsic(suchasgenotype, epigeneticmodifications, microbiome, and proteome)andextrinsic(includingsocialdeterminantsofhealth, behavioralpatterns, and culturalandreligiouspreferences)factorshasledtotheconceptofpersonalizednutrition. Manyotherterms, suchasprecisionnutrition, individualizednutrition, nutrigenetics, and nutrigenomics, are often used interchangeably, and a consensus on their definitions is lacking11. AsimpledefinitionproposedbyOrdovasetal. definespersonalizednutrition asanapproachthatusesinformationonindividualcharacteristicstodeveloptargeted nutritionaladvice, productsorservices12. The emergence of omics technologiessuch as genomics, transcriptomics, proteomics, andmetabolomicsalongwithadvancementsinbigdata, artificialintelligence, andsystemsbiology, hasfueledoptimismaboutleveragingprecisionnutritiontoprovide highlypersonalizeddietaryrecommendationsforeachindividual13. However, datademonstratingtheclinicalbenefitofsuchpreciseandhigh-costdietary advice are limited. The largest randomized controlled trial attempting to address this question, theFood4MeStudy, included1269adultsfromsevenEuropeancountries14. Participantswererandomizedtothefollowingfourdietaryadvicegroups: conventional, basedontheindividualbaselinediet; basedontheindividualbaselinedietplusphenotype; and based on the individual baseline diet plus phenotype plus genotype. While personalizednutritionwasmoreeffectivethanconventionaldietaryadvice, incorporating phenotypicorgenotypicinformationdidnotenhancetheeffectivenessofthepersonalized recommendations14. Examinationoftheimpactofprovidinggenotype-basedpersonalizednutritionaladviceonindividualsbehaviorfoundlimitedevidencesupportingits effectivenessinmotivatingbehaviorchange. Furthermore, geneticknowledgemayhave unintendednegativeconsequences, suchasincreaseddemotivationandanxiety15. Similarly, aCochranemeta-analysisreportednosignificanteffectofcommunicatingDNA-based riskestimatesondietarychanges, highlightingtheneedforfurtherinvestigationintothe utilityandpsychologicalimplicationsofsuchapproaches16. Despitetheselimitationsobservedinthegeneralpopulation, wearguethatpersonalizednutritionadvicemayholdpromiseinthemanagementofcomplexpatientswithCKD, asthecurrentnutritionalguidelinesforCKDfailtofullyaddresstheiruniquenutritional andmedicalchallenges. 3. CurrentStateofNutritionalRecommendationsinCKD Withdecliningkidneyfunction, theabilitytoexcretesodiumandotherelectrolytes, Water, acid, andothermetabolicwasteproductsisprogressivelyimpaired. Thus, traditional dietaryrecommendationsforpatientswithCKDprimarilyfocusonlimitingtheintake of Potassium, Sodium, and phosphorus to mitigate these challenges. Additionally, it is Biomedicines2025, 13, 647 3of17 well-established that High Protein intake contributes to glomerular hyperfiltration and elevatedintraglomerularpressure, withfurtherrenaldamage17, 18. However, balancing alltheserestrictions, alongwithothersthatareneededforthemanagementofcommon co-morbidities like Diabetes mellitus, often leaves patients with limited options for a nutritionallyadequateandsatisfyingdiet. Thisfrequentlyresultsinreducedadherence to dietary advice and greater frustration among patients. Emerging evidence suggests thatshiftingfromrigid, nutrient-specificrestrictionstopromotingoverallhealthydietary patterns, whichhelpslowtheprogressionofCKD, maybemorefeasibleandacceptablefor patientstofollow19, 20. 3. 1. RecommendedDietaryPatternsinCKDCare The Kidney Disease: Improving Global Outcomes (Kidney Disease: Improving Global Outcomes) 2024 Clinical Practice GuidelinefortheEvaluationandManagementofChronicKidneyDiseaserecommendsthat patientswithCKDadopthealthyanddiversedietswithgreaterconsumptionofplant-based foodscomparedtoanimal-basedfoodsandreducetheintakeofultraprocessedfoods21. Additionally, recommendationsemphasizetheimportanceofnutrientbioavailabilitybased onthefoodsource, forexample, recognizingthat(added)inorganicphosphorusisabsorbed moreefficientlythanorganic(natural)dietaryphosphorus22. Thisapproachissupported byevidencesuggestingthatplant-baseddietscanreduceproteinuria, decreasemetabolic acidosis, and slow chronic kidney disease progression by reducing cardio-metabolic risk factors, such as hypertension, cardiovasculardisease, Diabetes, andobesity, withoutsignificantlyimpairing phosphoruscontrol21. The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes consensus report on diabetesmanagementinCKDemphasizestheimportanceofindividualizedandbalanced diets that are High in vegetables, fruits, and whole grains but Low in refined carbohydratesandsugar-sweetenedbeverages. Bothguidelinesrecommendalow-sodiumdiet (Kidney Disease: Improving Global Outcomes2000mg/day; ADA1500to2300mg/day)tocontrolbloodpressureandreduce cardiovascularrisk23. Table1summarizesthetypesofdietsrecommendedinCKD. Table1. Overviewofthetypesofdietsinchronickidneydisease. TypeofDiet Advantages Disadvantages Carefulmonitoringofpotassiumand Helpscontrolmetabolicacidosis, proteinuriaand phosphoruslevelsisrequiredin inflammation; supportsthemicrobiomeand advancedstagesofCKD. Plant-baseddiet potentiallyslowsCKDprogression. Associated Deficienciesofessentialaminoacids, withlowerrisksofhypertension, diabetesmellitus, vitaminB12andlongchainn-3 cardiovasculardiseaseandmortality. polyunsaturatedfattyacidspossible. Cardioprotectiveandanti-inflammatoryeffects. It mayalsoimprovekidneyfunctionandmetabolic Mayrequirepotassiummonitoringin Mediterraneandiet profileandreduceinflammationanduremictoxin advancedCKD. production. Limitedproteinintakeisintendedtoreduce nitrogenouswastegenerationandslowkidney Excessiveproteinrestrictioncanleadto Low-proteinor functiondecline.",
    "Associated Deficienciesofessentialaminoacids, withlowerrisksofhypertension, diabetesmellitus, vitaminB12andlongchainn-3 cardiovasculardiseaseandmortality. polyunsaturatedfattyacidspossible. Cardioprotectiveandanti-inflammatoryeffects. It mayalsoimprovekidneyfunctionandmetabolic Mayrequirepotassiummonitoringin Mediterraneandiet profileandreduceinflammationanduremictoxin advancedCKD. production. Limitedproteinintakeisintendedtoreduce nitrogenouswastegenerationandslowkidney Excessiveproteinrestrictioncanleadto Low-proteinor functiondecline. malnutritionandmusclewasting, controlled-Protein Non-dialysisCKD: 0. 60. 8g/kg/day speciallyinpatientswithadvanced diet Kidney disease requiring Dialysis: chronic kidney disease. 1. 01. 2g/kg/day Biomedicines2025, 13, 647 4of17 Table1. Cont. TypeofDiet Advantages Disadvantages Verylow-Protein Canbesupplementedwithessentialaminoacids Requirescarefulmonitoringand diet(0. 3g/kg/day) andketoacidstopotentiallydelaytheprogression supplementationtoavoiddeficiencies withketoanalogue ofCKD. andensurenutritionaladequacy. supplementation Controlsbloodpressureandreduces Low-sodiumdiet Challengingtoadhereto. cardiovascularrisk. Risksincludenutrientdeficiencies, Mayhavebenefitsformetabolichealth, though dehydrationanddifficultyinadherence, Intermittentfasting limitedresearchexistsonitsrisksorbenefitsfor speciallyinpatientswithadvanced patientswithCKD. chronic kidney disease. 3. 2. EnergyIntake The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (Kidney Disease Outcomes Quality Initiative)recommendsanenergyintakeof2535kcal/kgbodyweightperdaytomaintain normalnutritionalstatusinmetabolicallystablepatientswithCKD22. ThisrecommendationisclassifiedasLevel1, GradeC(lowconfidence)becauseofalackofcontrolled metabolicstudiesandwell-designedlong-termclinicaltrialsassessingenergyintakeamong thispopulation22. Energyintakeshouldbeindividualizedbasedonfactorssuchasage, sex, activitylevel, bodycomposition, weightmanagementgoals, CKDstage, inflammation, andcomorbidities like Diabetes mellitus, cardiovascular disease, and obesity. Additionally, consideration mustbegiventotheriskofprotein-energywasting(protein-energy wasting)andtheneedtocontrolprotein intake. Inthiscontext, carbohydratesgenerallymakeupabout50%ofenergyintake, with therestfromproteinandfat24. 3. 3. ProteinIntake Fordietaryproteinintake, theADAandKDIGOrecommendtargeting0. 8g/kg/day, whiletheKDOQIsuggests0. 550. 60g/kg/dayaloneor0. 280. 43g/kg/day, withadditionalketoacid/aminoacidanaloguesformetabolicallystablepatientswithCKDwithout diabetesand0. 60. 8g/kg/dayforthosewithdiabetesandCKD23, 25. Higherprotein intakesshouldbeconsideredforpatientsonmaintenancedialysisbecauseoftheriskof malnutrition23. Thisrecommendationisbasedontheobservationfromanimalstudies that a lower Protein intake causes afferent arteriolar vasoconstriction, reducing the intraglomerularpressureandhyperfiltrationinjury26. Althoughtheresultsofhuman studiesonprotein-restricteddietshavebeenmixed, theoverallevidencesupportstherole of reduced Protein intake in limiting glomerular injury and proteinuria 27. Reducing proteinintake, particularlyfromanimalsources, hasbeenshowntolowertheproduction ofuremictoxins. Thiscanhelpdelaytheneedforrenalreplacementtherapyandalleviate uremicsymptomsinpatientsoptingforconservativemanagement28. Althoughclinicalpracticeguidelinesdonotspecifytheoptimalproteinsource(plantoranimal-based)citinginsufficientevidencefromrandomizedcontrolledtrials, observationalstudiesincreasinglysupporttheeffectivenessofplant-basedproteinsinreducing theincidenceandprogressionofCKD29, 30. ThishasledtheInternationalSocietyof RenalNutritionandMetabolismtorecommendthatitmaybereasonablefornutrition professionalstosuggestplant-basedproteinswithconsiderationofpatientpreferencesand culturalfoodhabits31. Biomedicines2025, 13, 647 5of17 Thisalignswiththeobservationthatmanyhealthydietarypatternsassociatedwith alowerriskofincidentCKD32andslowerprogressionofestablishedCKD19consistof adietrichinfruits, vegetables, andnutsandarelowerinredmeatsandprocessedfoods. 3. 4. AcidLoad, Phosphorus, andPotassiumBalance Highernetendogenousacidproduction(NEAP)isassociatedwithfasterCKDprogression. CurrentclinicalguidelinesrecommendreducingtheNEAPbymeansofgreater dietary intake of fruits and vegetables or by oral alkali therapy 22. Given the limited andmixedevidenceregardingtheeffectofhyperphosphatemiaonCKDprogression, currentguidelinesonlyrecommendadjustingdietaryphosphorusintaketomaintainserum phosphorusinthenormalrangeandtoconsiderdifferingbioavailabilityfromvarious dietary sources 22. Similarly, there was a weak recommendation (opinion) to adjust dietarypotassiumintaketomaintainserumpotassiumwithinthenormalrange. Thus, underthesupervisionofaskilledrenaldietician, itispossibletoimplementalow-Protein, plant-baseddietwithalowriskofinducingmusclewasting, frailty, hyperphosphatemia, andhyperkalemia. 3. 5. Omega-3PolyunsaturatedFattyAcids(n-3PUFAs)andKidneyDisease Studiesinanimalmodelsofchronicrenalfailureshowedreducedoxidativestress, inflammation, andfibrosisleadingtoreducedtubulointerstitialinjuryaftersupplementationwithdocosahexaenoicacid(DHA)andeicosapentaenoicacid(EPA)33. Inarecent pooledanalysisof25, 570participantsfrom19cohortsin12countriesmeasuringn-3PUFA biomarkerdata, higherlevelsoftotalseafoodn-3PUFAsbutnotplantn-3PUFAswere associatedwithalowerriskofincidentCKDandslowerdeclineinkidneyfunction34. Systematic reviews of randomized controlled trials of PUFA-3 supplementation found asignalofanimprovedlipidprofileandreducedoxidativestress, aswellasapossible beneficialeffectonpreventingESKDinpatientswithCKDnotyetonrenalreplacement therapy, albeit with very Low evidence certainty 35. In the absence of more definitive results from large, randomized, controlled clinical trials, current clinical guidelines do notrecommendtheuseofn-3PUFAsupplementationtopreventfurtherdeclineinrenal functioninCKDthoughtheydorecommendtheinclusionof250mg/dayoflongchainn-3 PUFAsfromoilyfishforthegeneralpopulationforahealthydiet36. 4. UniqueNutritionalChallengesinCKD PatientswithCKDfaceuniquechallenges, whichmakethepersonalizationofnutrition recommendationsessential(Figure1). Thesechallengesincludeprotein-energywasting (protein-energy wasting), sarcopenia, the Obesity paradox, and specific considerations for older adults with chronic kidney disease. Addressing these complexities requires a nuanced approach that considers individualpatientcharacteristics, comorbidities, andlifestylefactors. 4. 1. Protein-EnergyWastingandSarcopeniainCKD Decliningkidneyfunctionisoftenassociatedwithprotein-energywasting(protein-energy wasting)37, aconditioncharacterizedbynutritionalandmetabolicimbalancesleadingtothesimultaneousdepletionofbodyproteinandenergyreserves38. TheprevalenceofPEWin non-dialysisCKDpopulationshasbeenreportedtovarywidely, rangingfrom18%to75%, withincreasingrateswithCKDprogression39. Thisbroadrangeisattributedtothelack ofstandardizeddefinitions, differencesinassessmenttools, smallsamplesizes, andthe diversesocioeconomicconditionsofthecountrieswherethestudieswereconducted39. Biomedicines 2025, 13, x FOR PEER REVIEW 6 of 19 Biomedicines2025, 13, 647 6of17 Figure1. ChallengestooptimalnutritioninCKD. chronic kidney diseasechronickidneydisease; Low protein dietLow-Protein Figudriee 1t; . HChPaDllenhgiegsh t-op rooptteiimnadli netu; tPriEtWion inp rCoKteDin. - CenKeDrg y cwharostninicg potassium. idney disease; Low protein diet Low-Protein diet; HPD High-Protein diet; protein-energy wastingProtein-energy wasting. Ameta-analysisexaminingtheglobalprevalenceofPEWusingthesubjectiveglobal 4. 1. aPsrsoetsesinm-Eennetr(gSyG WAa)sotirntgh aenmd aSlanrucotrpietnioian inin CflKaDm mationscoreidentifiedonlyfivestudieson patientswithnon-dialysisCKD, reportingaPEWprevalenceof1154%39. Additionally, Declining Kidney function is often associated with Protein-energy wasting (protein-energy wasting) sarcopenia, acomponentofPEW, hasnowbeenrecognizedasadistinctconditionwithits 37, a condition characterized by nutritional and metabolic imbalances leading to the simownuniqueICDcode, withhandgripstrength(HGS)consideredasthesimplestandmost ultaneous depletion of body Protein and energy reserves 38. The prevalence of protein-energy wasting in practicalmarkerforitsassessment. UsingHGS, alongwithpoormusclemassandpoor non-Dialysis chronic kidney disease populations has been reported to vary widely, ranging from18% to 75%, functionalperformance, theprevalenceofsarcopeniaintheUKBiobankCKDpopulation with increasing rates with chronic kidney disease progression 39. This broad range is attributed to the lack wasestimatedat9. 7%, approximatelytwicetheprevalenceobservedinindividualswithout of standardized definitions, differences in assessment tools, small sample sizes, and the chronic kidney disease 40. It is important to diagnose and treat protein-energy wasting and sarcopenia in chronic kidney disease, as these diverse socioeconomic conditions of the countries where the studies were conducted 39. havebeenlinkedtoadverseoutcomes, includinggreaterriskoffrailty, hospitalizations, A meta-analysis examining the global prevalence of protein-energy wasting using the subjective global progression to Kidney failure, cardiovascular adverse events, and mortality, as well as assessment (SGA) or the malnutritioninflammation score identified only five studies on greaterhealthcarecosts21, 4044. patients with non-Dialysis chronic kidney disease, reporting a protein-energy wasting prevalence of 1154% 39.",
    "Additionally, TheetiologiesofPEWandsarcopeniainCKDaremultifactorialandincludeahypersarcopenia, a component of protein-energy wasting, has now been recognized as a distinct condition with catabolicstateinducedbyuremia, anorexia, andchronicinflammation45. CKDresults its own unique ICD code, with handgrip strength (HGS) considered as the simplest and in the disruption of multiple processes that normally regulate muscle metabolism 46. most practical marker for its assessment. Using HGS, along with poor muscle mass and chronic kidney disease-relatedchangesincludemitochondrialdysfunction, resultingininefficientenergy poor functional performance, the prevalence of sarcopenia in the UK Biobank chronic kidney disease popproduction, inflammation, andautophagy; impairedmusclerepairandregenerationdue ulation was estimated at 9. 7%, approximately twice the prevalence observed in individutoreducedproteinsynthesis; andexcessivemuscleatrophy. Additionally, dysregulation als without chronic kidney disease 40. It is important to diagnose and treat protein-energy wasting and sarcopenia in chronic kidney disease, of appetite hormones, like ghrelin and leptin, combined with inflammatory cytokines, as these have been linked to adverse outcomes, including greater risk of frailty, hospitalicontributestoappetitesuppressionandreducedfoodintake46. zations, progression to Kidney failure, cardiovascular adverse events, and mortality, as Metabolicacidosis, whichworsenswithCKDprogression, furtherexacerbatesthisby well as greater healthcare costs 21, 4044. promotinginsulinresistance, oxidativestress, andinflammationleadingtoproteinlossand The etiologies of protein-energy wasting and sarcopenia in chronic kidney disease are multifactorial and include a hypercatabolic state induced by uremia, anorexia, and chronic inflammation 45. chronic kidney disease results Biomedicines2025, 13, 647 7of17 malnutrition. Importantly, thetreatmentofmetabolicacidosishasbeenshowntomitigate theseeffects4749. Low-proteinandvery-Low-proteindiets, despiteconcernsaboutmusclewastingand frailty, havenotbeenshowntoacceleratetheirprogression46, 50. Studiessuggestthat patientscanadapttolow-proteindietsbyreducingmuscleproteindegradationandincreasingtheefficiencyofmuscleproteinturnover, ultimatelypreventingmusclewasting50. ThesedietsslowCKDprogressionbyreducingglomerularhyperfiltration, proteinuria, and productionofuremictoxins22, 51andbydecreasingnetendogenousacidproductionand mitigatingmetabolicacidosis25byfavoringplantproteinintakeoveranimalprotein. 4. 2. ObesityParadoxinCKD The Obesity paradox, where a higher body mass index (body mass index) is associated with bettersurvivaloutcomes, isobservedinbothdialysisandnon-dialysisCKDpopulations. However, theunderlyingmechanismsandclinicalimplicationsremaincomplexandrequire carefulinterpretation. In patients with non-Dialysis chronic kidney disease, several studies have demonstrated an inverse relationshipbetweenBMIandmortality. ABMIbelow25kg/m2 wasassociatedwithhigh mortalityratesacrossallCKDstages52. Also, alowerBMIwasassociatedwithgreater mortality in non-Dialysis chronic kidney disease, after adjusting for various confounders, such as demographics, comorbidities, andmarkersofmalnutritionandinflammation53. Conversely, a higherBMIwasassociatedwithareductioninall-causemortalityinCKDstages3554, 55. TheKDOQIguidelinesacknowledgethecomplexityoftherelationshipbetweenBMIand mortalityinpatientswithnon-dialysisCKD, statingthatoverweightorobesitystatusmay decreasemortalityriskinmetabolicallyhealthyindividuals22. Similarly, ahigherBMIinpatientswithkidneyfailurerequiringhemodialysisisconsistentlyassociatedwithimprovedsurvivalacrossvariousracialandregionalgroups56. However, theObesityparadoxislessconsistentinpatientsundergoingperitonealdialysis, whereresultsaremixed56, 57. Thoughthereasonsremainuncertain, asimilarreverseepidemiologyhasbeennoted inotherchronicdiseaseincludingchronicobstructivepulmonarydisease, heartfailure, cirrhosisandcancer58. ProposedexplanationsfortheObesityparadoxinCKDinclude atimediscrepancyincompetingriskfactorswithhighshort-termmortalityinadvanced CKDobscuringthelonger-termadverseeffectsofobesity; hemodynamicstabilityconferred by obesity; lipoprotein defense against endotoxins; protective cytokine profiles; toxin sequestrationbyfatmass; andantioxidationofmuscle58. Fatmassservesasanenergy reserveagainstcatabolicconditionscommonlyseeninpatientsonhemodialysis, andhigher fatmasshasbeenassociatedwithbettersurvival59. Highermusclemass, asindicated byserumcreatininelevels, isassociatedwithimprovedsurvival, suggestingthatbothfat andmusclemasscontributetotheObesityparadoxinCKD57. Thepathophysiology behindthisparadoxincludesfactorssuchasprotein-energywasting, inflammation, and themalnutritioninflammationcomplexsyndrome, whichareprevalentindialysispatients andmayalterthetypicalriskprofilesseeninthegeneralpopulation60. ThepotentialsurvivalbenefitofmildobesityinadvancedCKDmustbedistinguished fromthewell-documentedrenaldamagecausedbysevereobesity, aswellastheimprovementsinrenalfunctionobservedwithweight-lossinterventionsinindividualswithmild chronic kidney disease61. 4. 3. NutritionalManagementoftheOlderPatientwithCKD TheprevalenceofCKDincreaseswithage, reaching33%inadultsover65years62. Agingisaccompaniedbyreductionsinmusclemassandfunctionduetoincreasedcatabolic Biomedicines2025, 13, 647 8of17 andbluntedanabolicresponsesinmusclemetabolism, adecreaseinphysicalactivity, and reducedenergyintake63. Additionally, olderadults, particularlythosewithCKD, may alsospontaneouslyreduceproteinintake64. Thisincreasestheriskofmalnutrition, protein-energy wasting, andsarcopeniaintheolderpopulation, whichcorrelateswithincreasedfrailtyandpoorer prognosis. Thus, theKDIGO2024guidelinesrecommendindividualizedproteintargets basedonthepatientsclinicalstatus. Forolderadultswithstableorslowlyprogressing chronic kidney disease, a Protein intake of 1. 01. 2 g/kg/day is suggested to prevent malnutrition and sarcopenia. However, forthosewithsignificantCKDprogression, proteinrestrictionto 0. 60. 8g/kg/daymaybeappropriate, providedtheyaremetabolicallystable21, 63. GiventheelevatedoxidativestressinpatientswithCKD, cliniciansshouldensure adequateintakeofantioxidants, suchasvitaminsEandC, selenium, andzinc, whichare oftendeficientintheelderly22, asthismayhelpmitigateoxidativedamageandsupport musclehealth, reduceoxidativestressmarkers, andimproveclinicaloutcomes25. Regularmonitoringofnutritionalstatusandindividualizingdietaryplansbasedon thepatientsclinicalcondition, preferences, andqualityoflifeareessential. Thisrequiresa carefulpatient-centered, personalizedapproachthatincludesnutritionalscreeningusing validatedtools, carefulassessmentofnutritionalstatus, andmusclemassandfunction beforeandduringdietaryinterventions. Italsoinvolvesprovidingdietarycounselingto ensureadequateenergyandproteinintakes, alongwithpatienteducationandashared decision-makingprocesstooptimizeoutcomes63. 4. 4. Sex-RelatedDifferencesinNutrition Itisincreasinglyrecognizedthatsexinfluencesnutritionalintake, nutrientmetabolism, andmetabolicresponsetodietaryinterventionsinbothhumansandanimals65. Notable differencesincludelowercaloricconsumptionperkilogramofleanmassinfemalescomparedtomales; higherintakesoffruits, vegetables, carbohydrates, andfiberinfemales; andgreaterconsumptionoffat-andprotein-richfoodsinmales66. Additionally, men and women differ in their metabolic handling of glucose, lipids, and proteins, as well as in gut microbiome composition, which influence the development and treatment of conditionssuchasdiabetesandobesity65. Thesearefurtherinfluencedbychangingsex hormonelevelsoverthelifespan, suchasdecreasedfoodintakeduringthefollicularphase inwomen66andincreasedrisksofinsulinresistanceandtype2diabetesmellitus, aswell asosteoporosis, aftermenopause65. Currently, CKDnutritionalguidelinesdonotincludesex-specificrecommendations. However, thereisincreasinginterestinexaminingsex-differencesindietarypatternsand foodintake67andtheassociationbetweennutrition, musclemass, andstrength68inpatientswithCKD. Thus, currentnutritionalrecommendationsforpatientswithCKDdonot takeintoaccountthebiologicaldifferencesrelatedtonutritioninmenandwomen, making regularmonitoringofnutritionalstatusandindividualizationofdietaryplans, essential. 4. 5. FruitsandVegetables: BadwiththeGood? Metabolicacidosis, whichfrequentlydevelopswithworseningkidneyfunction, promotesdeclineinglomerularfiltrationandcontributestoextra-renalcomplications, such as muscle wasting, worsened metabolic bone disease, hypoalbuminemia, malnutrition, increasedinflammation, andincreasedmortality69. Toaddressthis, KDQOIguidelines recommenddecreasingnetacidexcretioninCKDstages14byincreasingintakeoffruits andvegetablesasdietarysourcesofalkali22. Thisapproachcontrastswiththetraditional advicetolimitfruitsandvegetablesinadvancedCKDinordertoavoidhyperkalemiaand hyperphosphatemia. However, studiesinpatientswithCKDstage370andstage471 haveshownthatselectedpatientswithadvancedCKDcansafelyincorporatefruitsand Biomedicines2025, 13, 647 9of17 vegetablesundertheguidanceofadietitian. Additionally, phosphorusfromplant-based sourcesislessbioavailablethanthatfromprocessedfoods22. 5. ImplementationofPersonalizedNutritionPlans 5. 1. CollaborationwithRenalDieticianandPatientEngagement TheRegisteredDietitianNutritionist(RDN)playsanimportantroleinthekidneycare team, particularlyintheassessmentofnutritionstatusandpreventionofprotein-energy malnutritionindialysispopulationsbyprovidingtargetedinterventions72. EarlyintegrationofRDNsinthecareofpatientswithCKDprovidesanopportunityforindividualized dietaryplanningtailoredtothepatientsCKDstageandnutritionalstatus. TheKDOQI 2020guidelinesrecommendmedicalnutritiontherapy(MNT)inCKDmanagement22to optimizepatientoutcomes, includingslowingdiseaseprogressionandmanagingcomorbid conditionssuchasdiabetesandcardiovasculardisease21. EarlyengagementofRDNs ensures personalization and dynamic adjustment of dietary interventions to reflect the evolvingnatureofthedisease, supportingbetterlong-termoutcomes22. Thesuccessoftheseinterventionsissignificantlyinfluencedbypatientengagement. Inthiscontext, telehealthcoachingprovidedbyRDNsisapowerfultooltoenhancedietary self-management in chronic kidney disease populations 73. Patients value the personalized approach, convenience, andempowermentprovidedbytelehealthcoaching, whichfacilitatesustainabledietarybehaviorchanges73. Telehealthcoachingdemonstrateshighretentionrates withpositivefeedbackfromparticipantsattestingtoitsfeasibilityandacceptability74. Alternatively, groupsettings, suchassharedmedicalappointments, canfosterpeersupport, whichhasbeenshowntoimprovepatientoutcomesinotherchronicconditions7577. 5. 2.",
    "Patients value the personalized approach, convenience, andempowermentprovidedbytelehealthcoaching, whichfacilitatesustainabledietarybehaviorchanges73. Telehealthcoachingdemonstrateshighretentionrates withpositivefeedbackfromparticipantsattestingtoitsfeasibilityandacceptability74. Alternatively, groupsettings, suchassharedmedicalappointments, canfosterpeersupport, whichhasbeenshowntoimprovepatientoutcomesinotherchronicconditions7577. 5. 2. CaseStudy1: ExampleofaPersonalizedNutritionPlaninCKD This case highlights the impact of personalized MNT in a patient with an active lifestyle, well-controlledtype 2 Diabetes and hypertension, chronic kidney disease stage 3B, and a recent diagnosisofrenalcellcarcinoma(Figure2). Thepatientwasreferredfornephrologycare forthemanagementofCKD3B. AstandardCKDdietwasrecommended, limitingprotein to0. 8g/kg/day(60g/day)and2000kcal/day. Inthesettingofongoingcancer, regular vigorous exercise, and dietary restrictions, the patient lost 10 pounds of weight over a couple of weeks. Recognizing the nutritional risks posed by cancer and unintentional weightloss, thenephrologistreferredthepatienttoadietitianspecializinginCKDfora tailoredintervention. Theinitialnutritionassessmentwasconductedeightdaysafterthereferralviatelehealth, for patient convenience. The patient and his wife shared their concerns about balancing dietary restrictions with maintaining nutrition. The dietitian implemented a personalizedplanfocusingonweightstabilization, recommendingincreasedcaloricintake (23003000kcal/day)andsodiumrestriction(2000mg/day). Proteinintakewasadjustedto aminimumof0. 9g/kg/day(70g/day)toaddressongoingweightloss, emphasizingplantbasedproteinsandhealthyfatswhileprioritizingcaloricadequacyoverstrictadherenceto renaldietparameters. Following the nephrectomy for renal cell carcinoma, the patient resumed physical activity(playingtennisforonehour, twoorthreedaysaweek), andcontinuedclosefollowupwiththedietitian. Asthecancertreatmentprogressed, thedietitianadvisedfurther liberalizationofproteinintake(80g/day)andinclusionofwholegrainstosupportcaloric needsandglycemiccontrol, coordinatedwiththepatientsnephrologistandoncologist. Overthenextyear, thepatientachievedstablenutritionalstatus, gainingback10pounds andmaintainingnormalserumphosphorus, Potassium, andalbuminlevels. Biomedicines 2025, 13, x FOR PEER REVIEW 10 of 19 B iomedicines2025, 13, 647 10of17 Figure2. CasestudyshowingimportanceofmedicalnutritiontherapyinmanagingcomplexcoFigure 2. Case study showing importance of medical nutrition therapy in managing complex comorbidities. chronic kidney diseasechronickidneydisease; diabetes mellitusdiabetesmellitus. morbidities. chronic kidney disease chronic Kidney disease; diabetes mellitus Diabetes mellitus. Thiscaseunderscoresthecriticalroleofearly, personalizedMNTinmanagingcomplex The initial nutrition assessment was conducted eight days after the referral via teleconcurrentmedicalconditionslikecancer. Thetailoredapproachallowedforflexibilityin health, for patient convenience. The patient and his wife shared their concerns about baldietaryrecommendationstomitigatenutritionalrisksassociatedwithcancertreatment, ancing dietary restrictions with maintaining nutrition. The dietitian implemented a perwhilecontinuouscommunicationwiththedietitianprovidedreassuranceandfacilitated sonalized plan focusing on weight stabilization, recommending increased caloric intake adherencetoanevolvingdietaryplan. (23003000 kcal/day) and Sodium restriction (2000 magnesium/day). Protein intake was adjusted 5to. 3 a. CmasineiSmtuudmy 2o: fE 0x. a9m gp/lkego/fdaaPy e(r7s0on ga/ldizaeyd)N tuot raidtidonrePssla onnfogroainngO wldeeirgFhetm loalsesP, aetmiepnthwasiitzhing Apldavnatn-bceadseCdK pDr, oFtoeoindsI natnodle rhaenacletsh, ya nfdatUs nwinhtielne tpiornioalriWtizeiignhgt cLaolsosric adequacy over strict adherenTchei stoc aresneahli dghielti gphatrsamtheetiemrsp. ortanceofpersonalizedMNTinlimitingunintentional weighFtolllooswsainngd tphreo tneeinphcareloctroiemmya flonru trreintiaoln cienlla cpaorcsitnmoemnao, p tahues aplawtieonmt arne. suAmne8d3 -pyehayrs-iocladl wacotimviatny w(piltahysintagg teen4nCisK fDo, r oosnteeo hpoourro, s tiws, oa nodr tihrrrietea bdleaybso aw weleseykn), d arnomd eco(nIBtiSn)uwedit hclcohsero fnoilcdloiwar-ruhpe awwitahs trheef edrireetdititaont. h Aesd tiheeti cciaanncearf tterreaextmpeernite npcrionggreasnseudn, itnhtee ndtiieotnitaialnlo asdsvoifse3d2% fuorfhtheerr bliobdeyrawlizeaigtihotn oovf eprrothteeinp rienctaekdein (g8f0o ugr/dyaeya)r American Society of Nephrology. dT oincallulesvioiant eoft hwehdoilae rgrhraeian, st thoe spuaptpieonrtt wcaalosriinc tnereeesdtse danind tgrlyyicnegmaicl ocown-tFrOolD, cMooArPdin(faetremde wntiathb lteheo lpigaotiseanctc(cid: 31)at bedtime anreidpehsr, odloigsaisctc hanadri doens-, mcoolongoissat. c Ochvaerri dthees, naenxdt ypeoalyr, o tlhse) dpiaetti. eSnht eachhaidevbeede nstafobcleu sniuntgriotinonliaml isttiantguss, a gltaiinntiankge bdaucke 1to0 hpeorukniddsn aenydd misaeiansteaainnidngw naosrcmoanlc seerrnuemd tphhaotsapdhdoirtuiosn, aplorteasstsriiucmtio, nasndth aaltbnuemedine dlevtoelfso. llow theloTwh-isF OcaDseM uAnPdedrisectowreosu tlhde eclriimtiicnaal treolneu otrf ieeanrtl-yri, cphefrosoondaslaizneddl MimNitTd ianir myaconnagsuinmgp ctoiomn-, wplhexic hcowncouurlrdenitm mpeadctichael rcoonsdteiotipoonrso lsiikse. cAandceier. t aTrhyer teacialollreredv aepaplerdoatchha taltlhoewpedat ifeonr tflwexaisibniltiotyle riann dtiteotahriyg heart rate-efcaotmfomodesndanatdiognlsu tteon -mfrietiegfartuec tnauntsr. itSiohneawl raisskasd vaissseodcitaoteldim witiftaht cinatnackeer ttroe4a0tm5e0ngt, pwehridlea cyoanntidnureoduus cceomfomodusnricicahtioinn gwluitthe nth-fer edeieftriuticatna npsr. ovTiodemda rienatassinuraadnecqeu aantde cfaacloilritiaeteadn dadchalecrieunmcei tnot aakne esv, oshlveinwga dsieetnacroyu pralagne. d to consume lower-fat dairy products. Additionally, she was recommended to increase the consumption of starchy foods like 5. 3. Case Study 2: Example of a Personalized Nutrition Plan for an Older Female Patient with boiledpotatoes, whiterice, andwhitebreadasprimarycaloricsourcesandtocontinueto lAimdviatnscoeddi uCmKDin, tFaokoed tIont2o0l0er0anmcgesp, aenrdd Uayn. intentional Weight Loss SThheisw caassea lhsoigehnlicgohutrsa tgheed itmopmoaritnatnacien oafc ponerssisotnenaltizeeadti nMgNscTh eidnu lliemwitiinthg fuounrinmteenatlisopnearl dwaeyi, gihntc llousdsi anngda plirgohtetibnr ceaalkofraiest m, dailnnnuetrr, itaionnd ians an pacokst, mineandodpiatuiosnalt woolumnacnh. , Awnh i8c3h-yweaars-holedr mwoaminamn ewailtohf stthaeged 4a yC. KTDhi, s oaspteporpooarcohsiasi, m anedd tiorriftaacbilliet abtoewdeigl esystniodnroamned (aIBchSi)e wveitahd cehqruoantiec Biomedicines2025, 13, 647 11of17 caloricintake. Withtheseinterventions, herweightandkidneyfunctionremainedstable, whileherpotassium, phosphorus, andalbuminlevelsstayedwithinnormalranges. ThiscasehighlightstheroleofpersonalizedMNTinstoppingongoinginvoluntary weightlossandpreventingmalnutritionwhilemanagingthecomplicationsofadvanced chronic kidney disease. Italsodemonstrateshowatailoreddietaryapproachcanhelpbalancenutritional needsdictatedbymultiplecomorbiditieswhileallowingthepatienttoenjoysomeoftheir favoritefood. 5. 4. BarrierstoNutritionPlansImplementation ThereareseveralbarrierstoreferraltoRDNsfornutritionassessmentandinterventionsforCKD78. Onesuchbarrieristheknowledgeofnon-dietetichealthprofessionals regardingtheimportanceofdietinmanagingCKD. Astudyfoundthatnon-dietetichealth professionalsratedtheimportanceofdietsignificantlylowerthanrenaldietitians78, and about50%ofthemreferredpatientstorenaldieteticservicesinfrequently, citingreasons suchasaperceivedlackofevidencesupportingtheroleofdietaryinterventionsinslowing CKDprogression, concernsaboutpatientadherence, andadesiretoreducevisitburden for patients 78. Another barrier is the inadequate staffing of dietetic services, leading to lengthy wait times for patients.",
    "Another barrier is the inadequate staffing of dietetic services, leading to lengthy wait times for patients. The model of shared medical appointment can help addressthisissueandreducewaittimes79. Additionally, theavailabilityofdietitians, particularlyinlow-andmiddle-incomecountries, islimitedanddietarycounselingisoften unavailable80. Despitestronginterestinmedicalnutritiontherapyamongpatientswith chronic kidney disease, practicalchallengesrelatedtocost, insurancecoverage, andreimbursementcontinue toposesignificantbarrierstoitsaccessibility81. 6. IndividualVariabilityinDietaryResponse: TheRoleofEpigenetics andPrecisionNutritioninCKD Theresponsetodietaryinterventionsvariessignificantlyamongindividuals82. This variabilityisdrivenbycomplexinteractionsbetweengenetic, epigenetic, metabolic, and environmentalfactors83, 84. Nutrigeneticsexamineshowgeneticvariationsinfluencean individualsresponsetodietaryintakeandsusceptibilitytonutrition-relateddiseases, while nutrigenomicsfocusesonhownutrientsaffectgeneexpression, impactingtheproteomeand metabolome85. Together, thesedisciplinesprovideafoundationforprecisionnutrition inCKDcare. Epigenetic modifications, including DNA methylation, histone modifications, and non-codingRNAactivity, arecriticalregulatorsofgeneexpressionandcontributetothe heterogeneityofdietaryresponsesinCKD84, 8688. Forexample, histoneacetylation promotesgeneexpression, whiledeacetylationrepressesit84. Nutrientssuchasbutyrate, ahistonedeacetylaseinhibitor, haveshownpotentialinmodulatingthesemodifications toameliorateCKDprogression88. AlteredDNAmethylationpatternsingenes, suchas interleukin6, transforminggrowthfactorbeta1, andparaoxonase1, whichareassociated withinflammation, oxidativestress, andfibrosis, caninfluenceanindividualsresponseto dietarysodiumandproteinrestrictions86, 88. 6. 1. MetabolomicsandProteomics Metabolomicandproteomicprofilingmayalsohelpclarifypatient-specificdietary responses. Biomarkers such as trimethylamine-N-oxide (TMAO) and urea cycle intermediateshavebeenidentifiedaspotentialindicatorsofhowpatientsrespondtoprotein intakeadjustments. Tailoreddietaryinterventions, suchasreducingintakeofcholine-and carnitine-richfoods(e. g. , redmeatandeggs), canbeimplementedtolowerTMAOlevels andmitigatecardiovascularrisk89, 90. Additionally, ureacycleintermediates, suchas Biomedicines2025, 13, 647 12of17 citrullineandarginine, arealsoimportantbiomarkersinCKD. Dietaryproteinrestriction can help manage urea cycle dysregulation, but the response to such interventions can vary91. 6. 2. Lipidomics chronic kidney disease leads to alterations in the concentration and structure of numerous lipid classes92, includingdysfunctionalhigh-densitylipoproteins(HDLs)enrichedwithceramidesandsphingomyelins, whichcontributetoapro-inflammatoryandpro-atherogenic state93. Impairedfattyacidsbeta-oxidationleadstotheaccumulationofsaturatedfree fattyacidsandlong-chainacylcarnitines94, shiftingthebalancefromdecreasedlevelsof polyunsaturatedfattyacids(PUFAs)inearly-stageCKDtowardincreasedshort-chainand saturatedfattyacidsinlate-stageCKD92, 94, 95. Additionally, lipidsincirculationcanaccumulateinthekidneysresultinginlipotoxicity, leadingtooxidativestress, inflammation, fibrosisandalbuminuria96. Thoughtherehasbeenextensiveresearchregardingtherole oflipidomicsbiomarkersinkidneydisease97, evidencethatdirectlytranslateslipidomic analysestotailorednutritionalinterventionsinCKDislacking. Nonetheless, lipidomicsis apromisingandevolvingfield, andfutureinvestigationsshouldclarifyhowlipidprofile alterationscanguidedietaryrecommendationsinCKD. 6. 3. GeneticIntegration Theintegrationofgeneticdataintodietaryplanninghasrevealedseveralcandidate genesinfluencingCKDprogressionandresponsetodiet. VariantsinUMOD(Uromodulin) andSHROOM3(SHROOMfamilymember3)geneshavebeenassociatedwithCKDprogressionandresponsetodietaryintervention, suggestingtheirpotentialasmarkersforguidingsodiumandproteinintakes98, 99. Similarly, APOL1variants, prevalentinindividuals ofAfricandescent, affectdietarysodiumsensitivityandproteinmetabolism, emphasizing the importance of population-specific considerations in precision nutrition 100. PolymorphisminMTHFR(methylenetetrahydrofolatereductase)geneimpactshomocysteine metabolism, whichisrelevantforpatientswithCKDbecauseofitsroleincardiovascular risk and response to folate intake 98. Variants in SOD2 (superoxide dismutase 2), an antioxidantenzyme, areassociatedwithoxidativestressandinflammationinCKDandcan guideantioxidantsupplementation101. Lastly, theCYP11B2(cytochromeP450family 11subfamilyBmember2)geneispartofthereninangiotensinaldosteronesystem, and itsvariantsareassociatedwithhypertensionandCKD. Thesemarkerscanguidedietary sodiumandpotassiummanagement98. Precisionnutritionstrategiesaimtoleveragetheseinsightsbydevelopingindividualizeddietaryplansthataccountforgeneticpredispositions, epigeneticmodifications, andbiomarkerprofiles. Forexample, apatientwithCKDandahigh-riskAPOL1genotypemaybenefitfromstrictersodiumrestrictionsandproteinmodificationstomitigate diseaseprogression. Similarly, incorporatingmetabolomicdatacanguideadjustmentsin micronutrientintaketoaddressdeficienciesortoxicitiesuniquetotheindividual. However, thehighcostsandcomplexityofgeneticandmetabolomictestinglimitits accessibilityinroutineclinicalpractice. Furthermore, long-termdataontheeffectiveness ofprecisionnutritionforCKDarescarce, withmoststudiesfocusingonshort-termoutcomessuchasbiomarkerchangesratherthanclinicallymeaningfulendpointslikeCKD progressionorcardiovascularevents. Despite the potential benefits of genetic testing in chronic kidney disease management, its clinical implementation remains limited. Many nephrologists underutilize genetic testing due to perceived barriers, including cost, complexity, and lack of familiarity with genetic data interpretation 102. While broad genetic panels, such as the 385-gene panel from Biomedicines2025, 13, 647 13of17 theRenasightstudy, haveshownutilityinimprovingdiagnosticprecisionandguiding management, theirintegrationintoroutinepracticeisstillinitsearlystagesandrequires furthervalidationandstandardization103. Addressingthesegapsrequiresrobust, multi-centerlongitudinaltrialsthatintegrate genetic, epigenetic, andmetabolomicdatawithreal-worldpatientoutcomes. Theintegrationofomicstechnologieswithculturalandsocioeconomicconsiderationsisessentialto ensurethatdietaryinterventionsarebotheffectiveandequitable. 7. Conclusions TheapplicationofprecisionnutritioninCKDrepresentsatransformativeapproach todietarymanagement, addressingtheheterogeneityofpatientneeds. Bytailoringinterventionstotheindividual, thisstrategyhasthepotentialtooptimizeoutcomes, mitigate risks, and improve the quality of life for patients with chronic kidney disease. Sustained research efforts andadvancementsinimplementationscienceareneededtofullyaddressthepotentialof personalizednutritioninthiscomplexandvulnerablepopulation. AuthorContributions: Conceptualization, M. D. ; writingoriginaldraftpreparation, N. P. , J. potassium. , M. D. ; writingreviewandediting, N. P. , J. potassium. , L. A. C. , M. D. ; supervision, M. D. Allauthorshavereadand agreedtothepublishedversionofthemanuscript. Funding: Thisresearchreceivednoexternalfunding. M. D. wasfundedbyAHA24TPA1299152. DataAvailabilityStatement: Nonewdatawerecreatedoranalyzedinthisstudy. Conflicts of Interest: N. P. serves on the Speakers Bureau for Boehringer-Ingelheim/Lilly. The remainingauthorshavenoconflictsofinteresttodeclare. References 1. Ying, M. ; Shao, X. ; Qin, H. ; Yin, P. ; Lin, Y. ; Wu, J. ; Ren, J. ; Zheng, Y. DiseaseBurdenandEpidemiologicalTrendsofChronicKidney DiseaseattheGlobal, Regional, NationalLevelsfrom1990to2019. Nephron2024, 148, 113123. CrossRef 2. GBD2017DietCollaborators. Healtheffectsofdietaryrisksin195countries, 19902017: AsystematicanalysisfortheGlobal BurdenofDiseaseStudy2017. Lancet2019, 393, 19581972. CrossRef 3. Micha, R. ; Peñalvo, J. L. ; Cudhea, F. ; Imamura, F. ; Rehm, C. D. ; Mozaffarian, D. AssociationBetweenDietaryFactorsandMortality FromHeartDisease, Stroke, andType2DiabetesintheUnitedStates. JAMA2017, 317, 912924. CrossRef 4. Bleich, S. N. ; Dupuis, R. ; Seligman, H. potassium. FoodIsMedicineMovement-KeyActionsInsideandOutsidetheGovernment. JAMA HealthForum2023, 4, e233149. CrossRef 5. Downer, S. ; Berkowitz, S. A. ; Harlan, T. S. ; Olstad, D. L. ; Mozaffarian, D. Foodismedicine: Actionstointegratefoodandnutrition intohealthcare. BMJ2020, 369, m2482. CrossRef 6. Martinez, J. A. ; Parra, M. D. ; Santos, J. L. ; Moreno-Aliaga, M. J. ; Marti, A. ; Martinez-Gonzalez, M. A. Genotype-dependentresponse toenergy-restricteddietsinobesesubjects: Towardspersonalizednutrition. AsiaPac. J. Clin. Nutr. 2008, 17(Suppl. S1), 119122. 7. Razquin, C. ; Marti, A. ; Martinez, J. A. Evidences on three relevant obesogenes: MC4R, FTO and PPARγ. Approaches for personalizednutrition. Mol. Nutr. FoodRes. 2011, 55, 136149. CrossRef 8. Juma, S. ; Imrhan, V. ; Vijayagopal, P. ; Prasad, C. Prescribingpersonalizednutritionforcardiovascularhealth: Areweready? J. Nutrigenet. Nutr. 2014, 7, 153160. CrossRef 9. Phillips, C. M. Nutrigeneticsandmetabolicdisease: Currentstatusandimplicationsforpersonalisednutrition. Nutrients2013, 5, 3257.",
    "J. Nutrigenet. Nutr. 2014, 7, 153160. CrossRef 9. Phillips, C. M. Nutrigeneticsandmetabolicdisease: Currentstatusandimplicationsforpersonalisednutrition. Nutrients2013, 5, 3257. CrossRef 10. Ling, C. ; DelGuerra, S. ; Lupi, R. ; Rönn, T. ; Granhall, C. ; Luthman, H. ; Masiello, P. ; Marchetti, P. ; Groop, L. ; DelPrato, S. Epigenetic regulationofPPARGC1Ainhumantype2diabeticisletsandeffectoninsulinsecretion. Diabetologia2008, 51, 615622. CrossRef 11. Bush, C. L. ; Blumberg, J. B. ; El-Sohemy, A. ; Minich, D. M. ; Ordovás, J. M. ; Reed, D. G. ; Behm, V. A. Y. TowardtheDefinitionof PersonalizedNutrition: AProposalbyTheAmericanNutritionAssociation. J. Am. Coll. Nutr. 2020, 39, 515. CrossRef 12. Ordovas, J. M. ; Ferguson, L. R. ; Tai, E. S. ; Mathers, J. C. Personalisednutritionandhealth. BMJ2018, 361, bmj. k2173. CrossRef 13. Mitchelson, potassium. A. J. ; MB, N. C. ; Roche, H. M. Systemsbiologyapproachestoinformprecisionnutrition. Proc. Nutr. Soc. 2023, 82, 208218. CrossRef Biomedicines2025, 13, 647 14of17 14. Celis-Morales, C. ; Livingstone, potassium. M. ; Marsaux, C. F. ; Macready, A. L. ; Fallaize, R. ; ODonovan, C. B. ; Woolhead, C. ; Forster, H. ; Walsh, M. C. ; Navas-Carretero, S. ; etal. Effectofpersonalizednutritiononhealth-relatedbehaviourchange: Evidencefromthe Food4MeEuropeanrandomizedcontrolledtrial. Int. J. Epidemiol. 2017, 46, 578588. CrossRef 15. ODonovan, C. B. ; Walsh, M. C. ; Gibney, M. J. ; Brennan, L. ; Gibney, E. R. Knowingyourgenes: Doesthisimpactbehaviourchange? Proc. Nutr. Soc. 2017, 76, 182191. CrossRef 16. Hollands, G. J. ; French, D. P. ; Griffin, S. J. ; Prevost, A. T. ; Sutton, S. ; King, S. ; Marteau, T. M. Theimpactofcommunicatinggenetic risksofdiseaseonrisk-reducinghealthbehaviour: Systematicreviewwithmeta-analysis. BMJ2016, 352, i1102. CrossRef 17. Albalate, M. ; Pérez-García, R. ; deSequera, P. ; Corchete, E. ; Alcazar, R. ; Ortega, M. ; Puerta, M. Isitusefultoincreasedialysateflow ratetoimprovethedeliveredKt? BMCNephrol. 2015, 16, 20. CrossRef 18. Cirillo, M. ; Lombardi, C. ; Chiricone, D. ; DeSanto, N. G. ; Zanchetti, A. ; Bilancio, G. Proteinintakeandkidneyfunctioninthemiddleagepopulation: Contrastbetweencross-sectionalandlongitudinaldata. Nephrol. Dial. Transpl. 2014, 29, 17331740. CrossRef 19. Hu, E. A. ; Coresh, J. ; Anderson, C. A. M. ; Appel, L. J. ; Grams, M. E. ; Crews, D. C. ; Mills, potassium. T. ; He, J. ; Scialla, J. ; Rahman, M. ; etal. AdherencetoHealthyDietaryPatternsandRiskofCKDProgressionandAll-CauseMortality: FindingsFromtheCRIC(Chronic RenalInsufficiencyCohort)Study. Am. J. KidneyDis. 2021, 77, 235244. CrossRef 20. Joshi, S. ; Kalantar-Zadeh, potassium. ; Chauveau, P. ; Carrero, J. J. RisksandBenefitsofDifferentDietaryPatternsinCKD. Am. J. KidneyDis. 2023, 81, 352360. CrossRef 21. KidneyDisease: ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes)CKDWorkGroup. KDIGO2024ClinicalPracticeGuidelineforthe EvaluationandManagementofChronicKidneyDisease. KidneyInt. 2024, 105, S117S314. CrossRef 22. Ikizler, T. A. ; Burrowes, J. D. ; Byham-Gray, L. D. ; Campbell, potassium. L. ; Carrero, J. J. ; Chan, W. ; Fouque, D. ; Friedman, A. N. ; Ghaddar, S. ; Goldstein-Fuchs, D. J. ; etal. KDOQIClinicalPracticeGuidelineforNutritioninCKD: 2020Update. Am. J. KidneyDis. 2020, 76, S1S107. CrossRef 23. de Boer, I. H. ; Khunti, potassium. ; Sadusky, T. ; Tuttle, potassium. R. ; Neumiller, J. J. ; Rhee, C. M. ; Rosas, S. E. ; Rossing, P. ; Bakris, G. Diabetes managementinchronickidneydisease: AconsensusreportbytheAmericanDiabetesAssociation(ADA)andKidneyDisease: ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes). KidneyInt. 2022, 102, 974989. CrossRef 24. MacLaughlin, H. L. ; Friedman, A. N. ; Ikizler, T. A. Nutrition in Kidney Disease: Core Curriculum 2022. Am. J. Kidney Dis. 2022, 79, 437449. CrossRef 25. Ikizler, T. A. ; Cuppari, L. The2020UpdatedKDOQIClinicalPracticeGuidelinesforNutritioninChronicKidneyDisease. Blood Purif. 2021, 50, 667671. CrossRef 26. Sällström, J. ; Carlström, M. ; Olerud, J. ; Fredholm, B. B. ; Kouzmine, M. ; Sandler, S. ; Persson, A. E. High-Protein-inducedglomerular hyperfiltrationisindependentofthetubuloglomerularfeedbackmechanismandnitricoxidesynthases. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299, R1263R1268. CrossRef 27. Kasiske, B. L. ; Lakatua, J. D. ; Ma, J. Z. ; Louis, T. A. Ameta-analysisoftheeffectsofdietaryproteinrestrictionontherateofdecline inrenalfunction. Am. J. KidneyDis. 1998, 31, 954961. CrossRef 28.",
    "Z. ; Louis, T. A. Ameta-analysisoftheeffectsofdietaryproteinrestrictionontherateofdecline inrenalfunction. Am. J. KidneyDis. 1998, 31, 954961. CrossRef 28. Brunori, G. ; Viola, B. F. ; Parrinello, G. ; DeBiase, V. ; Como, G. ; Franco, V. ; Garibotto, G. ; Zubani, R. ; Cancarini, G. C. Efficacyand safetyofavery-Low-proteindietwhenpostponingdialysisintheelderly: Aprospectiverandomizedmulticentercontrolledstudy. Am. J. KidneyDis. 2007, 49, 569580. CrossRef 29. Joshi, S. ; McMacken, M. ; Kalantar-Zadeh, potassium. Plant-BasedDietsforKidneyDisease: AGuideforClinicians. Am. J. KidneyDis. 2021, 77, 287296. CrossRef 30. Joshi, S. ; Hashmi, S. ; Shah, S. ; Kalantar-Zadeh, potassium. Plant-baseddietsforpreventionandmanagementofchronickidneydisease. Curr. Opin. Nephrol. Hypertens. 2020, 29, 1621. CrossRef 31. Kistler, B. M. ; Moore, L. W. ; Benner, D. ; Biruete, A. ; Boaz, M. ; Brunori, G. ; Chen, J. ; Drechsler, C. ; Guebre-Egziabher, F. ; Hensley, M. potassium. ; etal. TheInternationalSocietyofRenalNutritionandMetabolismCommentaryontheNationalKidneyFoundationand AcademyofNutritionandDieteticsKDOQIClinicalPracticeGuidelineforNutritioninChronicKidneyDisease. J. Ren. Nutr. 2021, 31, 116120. e1. CrossRef 32. Bach, potassium. E. ; Kelly, J. T. ; Palmer, S. C. ; Khalesi, S. ; Strippoli, G. F. M. ; Campbell, potassium. L. HealthyDietaryPatternsandIncidenceofCKD: AMeta-AnalysisofCohortStudies. Clin. J. Am. Soc. Nephrol. 2019, 14, 14411449. CrossRef 33. An, W. S. ; Kim, H. J. ; Cho, potassium. H. ; Vaziri, N. D. Omega-3fattyacidsupplementationattenuatesoxidativestress, inflammation, and tubulointerstitialfibrosisintheremnantkidney. Am. J. Physiol. Ren. Physiol. 2009, 297, F895F903. CrossRef 34. Ong, potassium. L. ; Marklund, M. ; Huang, L. ; Rye, potassium. A. ; Hui, N. ; Pan, X. F. ; Rebholz, C. M. ; Kim, H. ; Steffen, L. M. ; vanWesting, A. C. ; etal. Associationofomega3polyunsaturatedfattyacidswithincidentchronickidneydisease: Pooledanalysisof19cohorts. BMJ 2023, 380, e072909. CrossRef 35. Saglimbene, V. M. ; Wong, G. ; vanZwieten, A. ; Palmer, S. C. ; Ruospo, M. ; Natale, P. ; Campbell, potassium. ; Teixeira-Pinto, A. ; Craig, J. C. ; Strippoli, G. F. M. Effectsofomega-3polyunsaturatedfattyacidintakeinpatientswithchronickidneydisease: Systematicreview andmeta-analysisofrandomizedcontrolledtrials. Clin. Nutr. 2020, 39, 358368. CrossRef Biomedicines2025, 13, 647 15of17 36. Rimm, E. B. ; Appel, L. J. ; Chiuve, S. E. ; Djoussé, L. ; Engler, M. B. ; Kris-Etherton, P. M. ; Mozaffarian, D. ; Siscovick, D. S. ; Lichtenstein, A. H. SeafoodLong-Chainn-3PolyunsaturatedFattyAcidsandCardiovascularDisease: AScienceAdvisoryFromtheAmerican HeartAssociation. Circulation2018, 138, e35e47. CrossRef 37. Koppe, L. ; Fouque, D. ; Kalantar-Zadeh, potassium. Kidneycachexiaorprotein-energywastinginchronickidneydisease: Factsand numbers. J. CachexiaSarcopeniaMuscle2019, 10, 479484. CrossRef 38. Fouque, D. ; Kalantar-Zadeh, potassium. ; Kopple, J. ; Cano, N. ; Chauveau, P. ; Cuppari, L. ; Franch, H. ; Guarnieri, G. ; Ikizler, T. A. ; Kaysen, G. ; etal. Aproposednomenclatureanddiagnosticcriteriaforprotein-energywastinginacuteandchronickidneydisease. Kidney Int. 2008, 73, 391398. CrossRef 39. Carrero, J. J. ; Thomas, F. ; Nagy, potassium. ; Arogundade, F. ; Avesani, C. M. ; Chan, M. ; Chmielewski, M. ; Cordeiro, A. C. ; Espinosa-Cuevas, A. ; Fiaccadori, E. ; etal. GlobalPrevalenceofProtein-EnergyWastinginKidneyDisease: AMeta-analysisofContemporaryObservationalStudiesFromtheInternationalSocietyofRenalNutritionandMetabolism. J. Ren. Nutr. 2018, 28, 380392. CrossRef 40. Wilkinson, T. J. ; Miksza, J. ; Yates, T. ; Lightfoot, C. J. ; Baker, L. A. ; Watson, E. L. ; Zaccardi, F. ; Smith, A. C. Associationofsarcopenia withmortalityandend-stagerenaldiseaseinthosewithchronickidneydisease: AUKBiobankstudy. J. CachexiaSarcopenia Muscle2021, 12, 586598. CrossRef 41. Gadelha, A. B. ; Cesari, M. ; Correa, H. L. ; Neves, R. V. P. ; Sousa, C. V. ; Deus, L. A. ; Souza, M. potassium. ; Reis, A. L. ; Moraes, M. R. ; Prestes, J. ; etal. Effectsofpre-dialysisresistancetrainingonsarcopenia, inflammatoryprofile, andanemiabiomarkersinoldercommunitydwellingpatientswithchronickidneydisease: Arandomizedcontrolledtrial. Int. Urol. Nephrol. 2021, 53, 21372147. CrossRef 42. Moorthi, R. N. ; Avin, potassium. G. Clinicalrelevanceofsarcopeniainchronickidneydisease. Curr. Opin. Nephrol. Hypertens. 2017, 26, 219228. CrossRef 43. Beaudart, C. ; Zaaria, M. ; Pasleau, F. ; Reginster, J. Y. ; Bruyere, O. HealthOutcomesofSarcopenia: ASystematicReviewand Meta-Analysis. PLoSONE2017, 12, e0169548. CrossRef 44. Norman, potassium. ; Otten, L. Financial impact of sarcopenia or Low muscle massA short review. Clin. Nutr. 2019, 38, 14891495. CrossRef 45.",
    "; Otten, L. Financial impact of sarcopenia or Low muscle massA short review. Clin. Nutr. 2019, 38, 14891495. CrossRef 45. Hanna, R. M. ; Ghobry, L. ; Wassef, O. ; Rhee, C. M. ; Kalantar-Zadeh, potassium. APracticalApproachtoNutrition, Protein-EnergyWasting, Sarcopenia, andCachexiainPatientswithChronicKidneyDisease. BloodPurif. 2020, 49, 202211. CrossRefPubMed 46. Wang, X. H. ; Mitch, W. E. ; Price, S. R. Pathophysiologicalmechanismsleadingtomusclelossinchronickidneydisease. Nat. Rev. Nephrol. 2022, 18, 138152. CrossRef 47. Garibotto, G. ; Sofia, A. ; Russo, R. ; Paoletti, E. ; Bonanni, A. ; Parodi, E. L. ; Viazzi, F. ; Verzola, D. Insulinsensitivityofmuscleprotein metabolismisalteredinpatientswithchronickidneydiseaseandmetabolicacidosis. KidneyInt. 2015, 88, 14191426. CrossRef 48. Kraut, J. A. ; Madias, N. E. AdverseEffectsoftheMetabolicAcidosisofChronicKidneyDisease. Adv. ChronicKidneyDis. 2017, 24, 289297. CrossRef 49. Ho, J. Q. ; Abramowitz, M. potassium. Clinical Consequences of Metabolic Acidosis-Muscle. Adv. Chronic Kidney Dis. 2022, 29, 395405. CrossRefPubMed 50. Garibotto, G. ; Picciotto, D. ; Saio, M. ; Esposito, P. ; Verzola, D. Muscleproteinturnoverandlow-proteindietsinpatientswith chronickidneydisease. Nephrol. Dial. Transpl. 2020, 35, 741751. CrossRefPubMed 51. Rhee, C. M. ; Ahmadi, S. F. ; Kovesdy, C. P. ; Kalantar-Zadeh, potassium. Low-Protein diet for conservative management of chronic Kidney disease: A systematic review and meta-analysis of controlled trials. J. Cachexia Sarcopenia Muscle 2018, 9, 235245. CrossRefPubMed 52. Lu, J. L. ; Kalantar-Zadeh, potassium. ; Ma, J. Z. ; Quarles, L. D. ; Kovesdy, C. P. Associationofbodymassindexwithoutcomesinpatientswith chronic kidney disease. J. Am. Soc. Nephrol. 2014, 25, 20882096. CrossRefPubMed 53. Kovesdy, C. P. ; Anderson, J. E. ; Kalantar-Zadeh, potassium. Paradoxicalassociationbetweenbodymassindexandmortalityinmenwith CKDnotyetondialysis. Am. J. KidneyDis. 2007, 49, 581591. CrossRef 54. Ladhani, M. ; Craig, J. C. ; Irving, M. ; Clayton, P. A. ; Wong, G. Obesityandtheriskofcardiovascularandall-causemortalityin chronickidneydisease: Asystematicreviewandmeta-analysis. Nephrol. Dial. Transplant. 2017, 32, 439449. CrossRefPubMed 55. Ahmadi, S. F. ; Zahmatkesh, G. ; Ahmadi, E. ; Streja, E. ; Rhee, C. M. ; Gillen, D. L. ; DeNicola, L. ; Minutolo, R. ; Ricardo, A. C. ; Kovesdy, C. P. ; etal. AssociationofBodyMassIndexwithClinicalOutcomesinNon-Dialysis-DependentChronicKidneyDisease: A SystematicReviewandMeta-Analysis. CardiorenalMed. 2015, 6, 3749. CrossRef 56. Park, J. ; Ahmadi, S. F. ; Streja, E. ; Molnar, M. Z. ; Flegal, potassium. M. ; Gillen, D. ; Kovesdy, C. P. ; Kalantar-Zadeh, potassium. Obesityparadoxin end-stagekidneydiseasepatients. Prog. Cardiovasc. Dis. 2014, 56, 415425. CrossRef 57. Kalantar-Zadeh, potassium. ; Abbott, potassium. C. ; Salahudeen, A. potassium. ; Kilpatrick, R. D. ; Horwich, T. B. Survivaladvantagesofobesityindialysis patients. Am. J. Clin. Nutr. 2005, 81, 543554. CrossRef 58. Kalantar-Zadeh, potassium. ; Rhee, C. M. ; Chou, J. ; Ahmadi, S. F. ; Park, J. ; Chen, J. L. ; Amin, A. N. TheObesityParadoxinKidneyDisease: HowtoReconcileitwithObesityManagement. KidneyInt. Rep. 2017, 2, 271281. CrossRef 59. Okuno, S. SignificanceofAdiposeTissueMaintenanceinPatientsUndergoingHemodialysis. Nutrients2021, 13, 1895. CrossRef Biomedicines2025, 13, 647 16of17 60. Kalantar-Zadeh, potassium. ; Block, G. ; Humphreys, M. H. ; Kopple, J. D. Reverseepidemiologyofcardiovascularriskfactorsinmaintenance dialysispatients. KidneyInt. 2003, 63, 793808. CrossRef 61. Navaneethan, S. D. ; Yehnert, H. ; Moustarah, F. ; Schreiber, M. J. ; Schauer, P. R. ; Beddhu, S. Weightlossinterventionsinchronic kidneydisease: Asystematicreviewandmeta-analysis. Clin. J. Am. Soc. Nephrol. 2009, 4, 15651574. CrossRefPubMed 62. Johansen, potassium. L. ; Gilbertson, D. T. ; Li, S. ; Li, S. ; Liu, J. ; Roetker, N. S. ; Ku, E. ; Schulman, I. H. ; Greer, R. C. ; Chan, potassium. ; etal. ultrasound Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am. J. Kidney Dis. 2024, 83, A8A13. CrossRefPubMed 63. Piccoli, G. B. ; Cederholm, T. ; Avesani, C. M. ; Bakker, S. J. L. ; Bellizzi, V. ; Cuerda, C. ; Cupisti, A. ; Sabatino, A. ; Schneider, S. ; Torreggiani, M. ; et al.",
    "Nutritional status and the risk of malnutrition in older adults with chronic Kidney disease Implications for Low Protein intake and nutritional care: A critical review endorsed by ERN-European Renal Association and ESPEN. Clin. Nutr. 2023, 42, 443457. CrossRefPubMed 64. Mendonça, N. M. P. ; Hengeveld, L. M. ; Presse, N. ; Canhão, H. ; Simonsick, E. ; Kritchevsky, S. B. ; Farsijani, S. ; Gaudreau, P. ; Jagger, C. ; Visser, M. Proteinintake, physicalactivityandgripstrengthinEuropeanandNorthAmericancommunity-dwelling older adults: A pooled analysis of individual participant data from four longitudinal ageing cohorts. Br. J. Nutr. 2023, 129, 12211231. CrossRef 65. Chen, Y. ; Kim, M. ; Paye, S. ; Benayoun, B. A. SexasaBiologicalVariableinNutritionResearch: FromHumanStudiestoAnimal Models. Annu. Rev. Nutr. 2022, 42, 227250. CrossRef 66. Marino, M. ; Masella, R. ; Bulzomi, P. ; Campesi, I. ; Malorni, W. ; Franconi, F. Nutritionandhumanhealthfromasex-gender perspective. Mol. Asp. Med. 2011, 32, 170. CrossRef 67. Wilkinson, T. J. ; Lightfoot, C. J. ; Smith, A. C. ComparisonofDietaryPatternsandDailyFoodIntakeAcrossKidneyDiseaseStages inEngland: AnA-PosterioriClusterAnalysis. J. Ren. Nutr. 2025, 35, 90102. CrossRef 68. Do, J. Y. ; Kang, S. H. Sexdifferenceintheassociationamongnutrition, musclemass, andstrengthinperitonealdialysispatients. Sci. Rep. 2022, 12, 17900. CrossRef 69. Dobre, M. Acidosisinrenaldisease: Shouldwebeconcerned? Nephrol. Dial. Transplant. 2022, 37, 10431045. CrossRef 70. Goraya, N. ; Simoni, J. ; Jo, C. H. ; Wesson, D. E. Treatmentofmetabolicacidosisinpatientswithstage3chronickidneydiseasewith fruitsandvegetablesororalbicarbonatereducesurineangiotensinogenandpreservesglomerularfiltrationrate. KidneyInt. 2014, 86, 10311038. CrossRef 71. Goraya, N. ; Simoni, J. ; Jo, C. H. ; Wesson, D. E. AcomparisonoftreatingmetabolicacidosisinCKDstage4hypertensivekidney diseasewithfruitsandvegetablesorsodiumbicarbonate. Clin. J. Am. Soc. Nephrol. 2013, 8, 371381. CrossRef 72. potassium/DOQI, NationalKidneyFoundation. Clinicalpracticeguidelinesfornutritioninchronicrenalfailure. Am. J. KidneyDis. 2000, 35, S17S104. CrossRef 73. Warner, M. M. ; Tong, A. ; Campbell, potassium. L. ; Kelly, J. T. PatientsExperiencesandPerspectivesofTelehealthCoachingwithaDietitian toImproveDietQualityinChronicKidneyDisease: AQualitativeInterviewStudy. J. Acad. Nutr. Diet. 2019, 119, 13621374. CrossRef 74. Kelly, J. T. ; Warner, M. M. ; Conley, M. ; Reidlinger, D. P. ; Hoffmann, T. ; Craig, J. ; Tong, A. ; Reeves, M. ; Johnson, D. W. ; Palmer, S. ; etal. Feasibilityandacceptabilityoftelehealthcoachingtopromotehealthyeatinginchronickidneydisease: Amixed-methods processevaluation. BMJOpen2019, 9, e024551. CrossRefPubMed 75. Cole, R. E. ; Boyer, potassium. M. ; Spanbauer, S. M. ; Sprague, D. ; Bingham, M. Effectiveness of prediabetes nutrition shared medical appointments: Preventionofdiabetes. DiabetesEduc. 2013, 39, 344353. CrossRefPubMed 76. Menon, potassium. ; Mousa, A. ; deCourten, M. P. ; Soldatos, G. ; Egger, G. ; deCourten, B. SharedMedicalAppointmentsMayBeEffectivefor ImprovingClinicalandBehavioralOutcomesinType2Diabetes: ANarrativeReview. Front. Endocrinol. 2017, 8, 263. CrossRef 77. Shibuya, potassium. ; Pantalone, potassium. M. ; Burguera, B. VirtualSharedMedicalAppointments: ANovelTooltoTreatObesity. Endocr. Pract. 2018, 24, 11081109. CrossRef 78. Notaras, S. ; Lambert, potassium. ; Perz, J. ; Makris, A. Diet in the management of non-Dialysis dependent chronic Kidney disease: Perceptionsandpracticesofhealthprofessionals. BMCNephrol. 2022, 23, 158. CrossRef 79. Jhagroo, R. A. ; Nakada, S. Y. ; Penniston, potassium. L. Sharedmedicalappointmentsforpatientswithkidneystonesnewtomedical managementdecreaseappointmentwaittimeandincreasepatientknowledge. J. Urol. 2013, 190, 17781784. CrossRef 80. Wang, A. Y. ; Okpechi, I. G. ; Ye, F. ; Kovesdy, C. P. ; Brunori, G. ; Burrowes, J. D. ; Campbell, potassium. ; Damster, S. ; Fouque, D. ; Friedman, A. N. ; etal. AssessingGlobalKidneyNutritionCare. Clin. J. Am. Soc. Nephrol. 2022, 17, 3852. CrossRef 81. Jimenez, E. Y. ; Kelley, potassium. ; Schofield, M. ; Brommage, D. ; Steiber, A. ; Abram, J. potassium. ; Kramer, H. MedicalNutritionTherapyAccessin chronic kidney disease: ACross-sectionalSurveyofPatientsandProviders. KidneyMed. 2021, 3, 3141. e1. CrossRef 82. Lampe, J. W. ; Navarro, S. L. ; Hullar, M. A. ; Shojaie, A. Inter-individualdifferencesinresponsetodietaryintervention: Integrating omicsplatformstowardspersonaliseddietaryrecommendations. Proc. Nutr. Soc. 2013, 72, 207218. CrossRefPubMed 83. Wang, A. Y. ; Kalantar-Zadeh, potassium. ; Fouque, D. ; Wee, P. T. ; Kovesdy, C. P. ; Price, S. R. ; Kopple, J. D. PrecisionMedicineforNutritional ManagementinEnd-StageKidneyDiseaseandTransitiontoDialysis. Semin. Nephrol. 2018, 38, 383396. CrossRef Biomedicines2025, 13, 647 17of17 84. Kushwaha, potassium.",
    "Semin. Nephrol. 2018, 38, 383396. CrossRef Biomedicines2025, 13, 647 17of17 84. Kushwaha, potassium. ; Garg, S. S. ; Gupta, J. Targeting epigenetic regulators for treating diabetic nephropathy. Biochimie 2022, 202, 146158. CrossRefPubMed 85. Ferguson, L. R. ; DeCaterina, R. ; Gorman, U. ; Allayee, H. ; Kohlmeier, M. ; Prasad, C. ; Choi, M. S. ; Curi, R. ; deLuis, D. A. ; Gil, A. ; etal. GuideandPositionoftheInternationalSocietyofNutrigenetics/NutrigenomicsonPersonalisedNutrition: Part1Fields ofPrecisionNutrition. J. Nutrigenet. Nutrigenomics2016, 9, 1227. CrossRefPubMed 86. Cappuccilli, M. ; Bergamini, C. ; Giacomelli, F. A. ; Cianciolo, G. ; Donati, G. ; Conte, D. ; Natali, T. ; LaManna, G. ; Capelli, I. VitaminB SupplementationandNutritionalIntakeofMethylDonorsinPatientswithChronicKidneyDisease: ACriticalReviewofthe ImpactonEpigeneticMachinery. Nutrients2020, 12, 1234. CrossRef 87. Mafra, D. ; Esgalhado, M. ; Borges, N. A. ; Cardozo, L. ; Stockler-Pinto, M. B. ; Craven, H. ; Buchanan, S. J. ; Lindholm, B. ; Stenvinkel, P. ; Shiels, P. G. Methyl Donor Nutrients in Chronic Kidney Disease: Impact on the Epigenetic Landscape. J. Nutr. 2019, 149, 372380. CrossRef 88. Reddy, M. A. ; Natarajan, R. Recent developments in epigenetics of acute and chronic Kidney diseases. Kidney Int. 2015, 88, 250261. CrossRef 89. Dubin, R. F. ; Rhee, E. P. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention. Clin. J. Am. Soc. Nephrol. 2020, 15, 404411. CrossRef 90. Wu, I. W. ; Chang, L. C. ; Wu, Y. L. ; Yang, H. Y. ; Twu, Y. C. ; Tsai, P. Y. ; Paulus, S. ; Resnick, R. ; Chung, W. H. ; Yang, C. W. ; etal. Gutflora metagenomicanalysiscoupledwithmetabolicanddeepimmuneprofilinginchronickidneydisease. Nephrol. Dial. Transpl. 2024, 39, 13331343. CrossRef 91. Wang, H. ; Ainiwaer, A. ; Song, Y. ; Qin, L. ; Peng, A. ; Bao, H. ; Qin, H. Perturbedgutmicrobiomeandfecalandserummetabolomes areassociatedwithchronickidneydiseaseseverity. Microbiome2023, 11, 3. CrossRef 92. Baek, J. ; He, C. ; Afshinnia, F. ; Michailidis, G. ; Pennathur, S. Lipidomicapproachestodissectdysregulatedlipidmetabolismin kidneydisease. Nat. Rev. Nephrol. 2022, 18, 3855. CrossRef 93. Lidgard, B. ; Hoofnagle, A. N. ; Zelnick, L. R. ; deBoer, I. H. ; Fretts, A. M. ; Kestenbaum, B. R. ; Lemaitre, R. N. ; Robinson-Cohen, C. ; Bansal, N. High-DensityLipoproteinLipidomicsinChronicKidneyDisease. Clin. Chem. 2023, 69, 273282. CrossRefPubMed 94. Afshinnia, F. ; Rajendiran, T. M. ; Soni, T. ; Byun, J. ; Wernisch, S. ; Sas, potassium. M. ; Hawkins, J. ; Bellovich, potassium. ; Gipson, D. ; Michailidis, G. ; etal. Impairedβ-OxidationandAlteredComplexLipidFattyAcidPartitioningwithAdvancingCKD. J. Am. Soc. Nephrol. 2018, 29, 295306. CrossRefPubMed 95. Speer, T. ; Ridker, P. M. ; vonEckardstein, A. ; Schunk, S. J. ; Fliser, D. Lipoproteinsinchronickidneydisease: Frombenchtobedside. Eur. HeartJ. 2021, 42, 21702185. CrossRefPubMed 96. Pan, X. TheRolesofFattyAcidsandApolipoproteinsintheKidneys. Metabolites2022, 12, 462. CrossRef 97. Afshinnia, F. ; Rajendiran, T. M. ; Wernisch, S. ; Soni, T. ; Jadoon, A. ; Karnovsky, A. ; Michailidis, G. ; Pennathur, S. Lipidomicsand BiomarkerDiscoveryinKidneyDisease. Semin. Nephrol. 2018, 38, 127141. CrossRef 98. Corredor, Z. ; Filho, M. ; Rodriguez-Ribera, L. ; Velazquez, A. ; Hernandez, A. ; Catalano, C. ; Hemminki, potassium. ; Coll, E. ; Silva, I. ; Diaz, J. M. ; etal. GeneticVariantsAssociatedwithChronicKidneyDiseaseinaSpanishPopulation. Sci. Rep. 2020, 10, 144. CrossRef 99. Prokop, J. W. ; Yeo, N. C. ; Ottmann, C. ; Chhetri, S. B. ; Florus, potassium. L. ; Ross, E. J. ; Sosonkina, N. ; Link, B. A. ; Freedman, B. I. ; Coppola, C. J. ; etal. CharacterizationofCoding/NoncodingVariantsforSHROOM3inPatientswithCKD. J. Am. Soc. Nephrol. 2018, 29, 15251535. CrossRef 100. Govender, M. A. ; Brandenburg, J. T. ; Fabian, J. ; Ramsay, M. TheUseofOmicsforDiagnosingandPredictingProgressionof ChronicKidneyDisease: AScopingReview. Front. Genet. 2021, 12, 682929. CrossRef 101. Corredor, Z. ; daSilvaFilho, M. I. ; Rodriguez-Ribera, L. ; Catalano, C. ; Hemminki, potassium.",
    "2021, 12, 682929. CrossRef 101. Corredor, Z. ; daSilvaFilho, M. I. ; Rodriguez-Ribera, L. ; Catalano, C. ; Hemminki, potassium. ; Coll, E. ; Silva, I. ; Diaz, J. M. ; Ballarin, J. A. ; Henandez, A. ; etal. Lociassociatedwithgenomicdamagelevelsinchronickidneydiseasepatientsandcontrols. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2020, 852, 503167. CrossRefPubMed 102. Knoers, N. ; vanEerde, A. M. TheRoleofGeneticTestinginAdultCKD. J. Am. Soc. Nephrol. 2024, 35, 11071118. CrossRefPubMed 103. Dahl, N. potassium. ; Bloom, M. S. ; Chebib, F. T. ; Clark, D. ; Westemeyer, M. ; Jandeska, S. ; Zhang, Z. ; Milo-Rasouly, H. ; Kolupaeva, V. ; Marasa, M. ; etal. TheClinicalUtilityofGeneticTestingintheDiagnosisandManagementofAdultswithChronicKidneyDisease. J. Am. Soc. Nephrol. 2023, 34, 20392050. CrossRefPubMed Disclaimer/PublishersNote: Thestatements, opinionsanddatacontainedinallpublicationsaresolelythoseoftheindividual author(s)andcontributor(s)andnotofMDPIand/ortheeditor(s). MDPIand/ortheeditor(s)disclaimresponsibilityforanyinjuryto peopleorpropertyresultingfromanyideas, methods, instructionsorproductsreferredtointhecontent."
  ],
  "metadatas": [
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 0,
      "content_type": "dietary",
      "content_type_confidence": 9,
      "word_count": 598,
      "entity_count": 9,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,sodium,potassium,phosphorus,nutrition,diet,acidosis,cardiovascular disease,physical activity",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 1,
      "content_type": "dietary",
      "content_type_confidence": 10,
      "word_count": 583,
      "entity_count": 10,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,kidney function,kidney failure,proteinuria,potassium,phosphorus,diet,low protein diet,dialysis,hyperphosphatemia",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 2,
      "content_type": "dietary",
      "content_type_confidence": 8,
      "word_count": 574,
      "entity_count": 7,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,kidney failure,proteinuria,malnutrition,dialysis,hyperphosphatemia,bone disease",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 3,
      "content_type": "dietary",
      "content_type_confidence": 9,
      "word_count": 594,
      "entity_count": 10,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,sodium,potassium,phosphorus,magnesium,nutrition,sodium restriction,caloric intake,dietitian,exercise",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 4,
      "content_type": "dietary",
      "content_type_confidence": 10,
      "word_count": 600,
      "entity_count": 5,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,urea,potassium,nutrition,quality of life",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 5,
      "content_type": "evidence",
      "content_type_confidence": 7,
      "word_count": 584,
      "entity_count": 2,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium,nutrition",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 6,
      "content_type": "dietary",
      "content_type_confidence": 7,
      "word_count": 589,
      "entity_count": 1,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 7,
      "content_type": "dietary",
      "content_type_confidence": 5,
      "word_count": 583,
      "entity_count": 6,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,potassium,diet,dialysis,acidosis,metabolic acidosis",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 8,
      "content_type": "dietary",
      "content_type_confidence": 8,
      "word_count": 594,
      "entity_count": 6,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": true,
      "medical_entities": "chronic kidney disease,potassium,nutrition,diet,malnutrition,dialysis",
      "year": "2025",
      "organization": "Unknown",
      "section": "Nutritional status and the risk of malnutrition in older adults with chronic Kidney disease Implicat"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 9,
      "content_type": "dietary",
      "content_type_confidence": 6,
      "word_count": 594,
      "entity_count": 3,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,nephropathy,potassium",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "4cf36d05570495ccc36d867768444e076b22.pdf",
      "chunk_id": 10,
      "content_type": "dietary",
      "content_type_confidence": 1,
      "word_count": 118,
      "entity_count": 1,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium",
      "year": "2025",
      "organization": "Unknown"
    }
  ],
  "ids": [
    "4cf36d05570495ccc36d867768444e076b22_0",
    "4cf36d05570495ccc36d867768444e076b22_1",
    "4cf36d05570495ccc36d867768444e076b22_2",
    "4cf36d05570495ccc36d867768444e076b22_3",
    "4cf36d05570495ccc36d867768444e076b22_4",
    "4cf36d05570495ccc36d867768444e076b22_5",
    "4cf36d05570495ccc36d867768444e076b22_6",
    "4cf36d05570495ccc36d867768444e076b22_7",
    "4cf36d05570495ccc36d867768444e076b22_8",
    "4cf36d05570495ccc36d867768444e076b22_9",
    "4cf36d05570495ccc36d867768444e076b22_10"
  ]
}